Turn Therapeutics Inc. (TTRX) › Shareholders' EquityTurn Therapeutics Inc. (TTRX) — Shareholders' EquityAnnual figures by period end, from SEC filings.2023-12-31: $85.8K2024-12-31: -$177.4K2025-12-31: $4.69M$4.69M2023-12-31Shareholders' Equity (USD)2025-12-31Period endedShareholders' EquityChange YoYSource filing2025-12-31$4.69M—2026-03-31Balance as of period end2024-12-31-$177.4K-306.9%2026-03-31Balance as of period end2023-12-31$85.8K—2026-03-31Balance as of period endOther metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per ShareWeighted Average Diluted SharesEPS (Basic)